Edze Rients Westra

2020 United Kingdom Award Finalist — Faculty

Current Position:
Professor of Microbiology and NERC Independent Research Fellow

Institution:
University of Exeter

Discipline:
Ecology

Recognized for: Discovering how ecology can drive the evolution of the bacterial CRISPR immune system to battle the viruses—or phages—that infect bacteria and how a greater understanding of the evolution of the CRISPR immune system may aid in tackling the problem of anti-microbial resistance.

Areas of Research Interest and Expertise:

Evolutionary Biology, Gene Editing, Bacterial Immunity, Antimicrobial Resistance, Phage biology

Previous Positions:

BSc, Wageningen University, Netherlands
MSc, Wageningen University, Netherlands
PhD, Wageningen University, Netherlands (Advisor: Prof. John van der Oost)
Marie Curie Fellow, University of Exeter (Advisor: Prof. Angus Buckling)

Research Summary:

Prof. Edze Westra’s work seeks to understand how selection pressures drive the evolution of bacterial defense strategies. Bacteria and bacteria-infecting viruses (known as phages) maintain a host-parasite relationship. When unobstructed, viruses infect bacteria and replicate until the bacteria is destroyed. Thus, bacteria have evolved a molecular immune response to fight infection—a mechanism that is key to their survival. Similarly, phages evolve to overcome bacterial immunity, resulting in a co-evolutionary arms race between the bacteria and phage. Using a combination of evolutionary theory, lab experiments, and genetic information, Westra studies the evolution of the adaptive bacterial immune system CRISPR-Cas, a dynamic group of proteins that aid bacteria in fighting off viruses. Westra first pioneered research into the detailed mechanism of CRISPR-Cas by demonstrating that a protein complex containing both CRISPR-associated proteins and virus-targeting genetic material is necessary for immunity function. Such findings were foundational for the field of CRISPR-associated gene-editing research, and he has since provided further studies of CRISPR-Cas regulation, high-resolution visualization of the CRISPR-Cas proteins, and identification of CRISPR-evading mutations within viruses. Further, Westra identified factors that determine whether or not the bacterial CRISPR-Cas system will be engaged in fighting viral infections, which has helped to resolve a long-standing discrepancy between nature- and lab-based studies. Westra’s work on interactions between bacteria and their parasites has provided key insight into methods for successfully predicting and manipulating evolution of CRISPR-Cas antiviral immunity and is indispensable to an understanding of antibiotic resistance, the development of novel antimicrobials, and bacteria-enabled biotechnology.

"I am honoured to be a Finalist for the 2020 Blavatnik Awards in the UK. I wish to thank the Blavatnik Family Foundation for this prestigious accolade, which will fuel further interest in this research field, and my lab members for their creativity and resolve."

Key Publications:

1. S. van Houte, A.K. Ekroth, J.M. Broniewski, H. Chabas, B. Ashby, J. Bondy-Denomy, S. Gandon, M. Boots, S. Paterson, A. Buckling, E.R. Westra. The Diversity-generating Benefits of a Prokaryotic Adaptive Immune System. Nature, 2016.
2. M. Landsberger, S. Gandon, S. Meaden, C. Rollie, A. Chevallereau, H. Chabas, A. Buckling, E.R. Westra, S. van Houte. Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity. Cell, 2018.
3. C Rollie*, A Chevallereau*, B.N.J. Watson, T Chyou, O Fradet, I McLeod, P.C. Fineran, C.M. Brown, S. Gandon, E.R Westra. Targeting of temperate phages drives loss of type I CRISPR-Cas systems. Nature, 2019.
4. E.O. Alseth, E. Pursey, A.M. Luján, I. McLeod, C. Rollie, E.R. Westra. Bacterial Biodiversity Drives the Evolution of CRISPR-based Phage Resistance in Pseudomonas Aeruginosa. Nature, 2019.

Other Honors:

In the Media:

Scientific American – 5 Big Mysteries about CRISPR's Origins

The Economist – Viruses That Attack Bacteria Have Evolved to Collaborate

Independent – Gene Editing Could Bring an End to All Inherited Disease and Cancer, Expert Says

Westra Lab

Staff Profile